Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mana

Request full access

An AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy

Tel Aviv-Yafo, IsraelFounded 2021Biotech & Life Sciences

About Mana

Mana.bio is a cutting-edge startup operating in the biotechnology sector, specifically focusing on drug delivery systems. The company leverages artificial intelligence (AI) and nanotechnology to revolutionize the delivery of gene therapies, including DNA and RNA-based therapeutics, and vaccines.

The company's primary clients are likely to be pharmaceutical and biotechnology firms seeking to enhance the efficacy and safety of their drug delivery systems. By operating in the rapidly growing field of gene therapy, Mana.bio is well-positioned to tap into a market that is projected to reach $10 billion by 2025.

Mana.bio's business model is centered around the application of machine learning, a subset of AI that involves the development of algorithms that improve over time through experience. The company uses machine learning to optimize the delivery of gene therapies and vaccines, potentially reducing side effects and improving patient outcomes.

In terms of revenue generation, while specific details are not publicly available, it's likely that Mana.bio earns income through partnerships with pharmaceutical and biotech companies, licensing its technology, or providing services related to drug delivery optimization.

The company is led by a team of seasoned entrepreneurs and respected experts in drug delivery, machine learning, and software development. They are driven by the potential of merging advanced technologies in biology and medicine to disrupt the drug delivery space.

Source: Dealroom company data

At a glance

Status
Operational
Employees
19
Open positions
None listed
Dealroom signal
73.5/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotechnology, Drug Development, Vaccines, Core AI, Spinout, Biotech and Pharma, AI Drug Discovery
Technology
Artificial Intelligence, Deep Tech
Business model
SaaS
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Oct 2023 $15M $58M Andreessen Horowitz · LionBird · NFX · Technion Israel Institute of Technology ↗
SEED✓Equity / VC Oct 2022 $5M $20M Undisclosed ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Mana website traffic

Latest recorded traffic for Mana is 3.6K monthly website visits, up 2.9% over the last three months. Mana's team declined 9.5% over the past year.

Latest monthly visits3.6K 3-month web change+2.9% 1-year team growth-9.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Mana in the Tel Aviv-Yafo ecosystem

Live from Dealroom

The Mana office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Mana’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.